IBM and Cleveland Clinic Collaborate on AI and Quantum Technology in Life Sciences

Three leading organizations have forged a partnership aimed at revolutionizing healthcare and advancing biomedical science through cutting-edge computing technologies, including artificial intelligence (AI) and quantum computing. IBM, Cleveland Clinic, and the Hartree Center, which is part of the U.K. Science and Technology Facilities Council (STFC), are collaborating to implement innovative strategies designed to enhance patient outcomes.

Lara Jehi, Cleveland Clinic’s Chief Research Information Officer, remarked, “This international collaboration brings together a multidisciplinary team of scientists, clinical researchers, and physicians from across industry, government, and healthcare.” This diverse team will harness high-performance computing and quantum technology to propel research in the life sciences, ultimately seeking to improve healthcare and accelerate the development of new treatments on a global scale. Notably, Cleveland Clinic London will serve as a vital link between groundbreaking clinical care in the UK and the broader global efforts of Cleveland Clinic.

The research initiative will kick off with two primary projects involving teams from IBM and the Hartree Center, with additional support from the Hartree National Centre for Digital Innovation, a partnership between IBM and the Hartree Center.

The first project will leverage advanced AI tools to analyze the effects of standard hospital procedures on patients at Cleveland Clinic London, focusing on how these interventions impact overall health and quality of life.

The second project will delve into the realm of quantum computing to scrutinize vast data sets, aiming to identify molecular characteristics that can more accurately predict surgical responses in patients suffering from epilepsy. By pinpointing biomarkers, the researchers aspire to develop personalized treatment plans that enhance patient care and clinical outcomes.

Alessandro Curioni, an IBM Fellow and Director at IBM Research Zurich, stated, “This partnership will play a crucial role in advancing research into the application of cutting-edge computation within healthcare and life sciences. We look forward to collaborating with researchers from Cleveland Clinic London and the Hartree Center to explore promising avenues for discovery across AI, quantum computing, and beyond.”

The research team will begin by utilizing clinical and advanced imaging data sourced from Cleveland Clinic London BioResource, with explicit patient consent. This data will serve as the foundation for training AI models, which will later expand to integrate a broader array of data types for comprehensive analysis across various diseases.

Through this innovative partnership, exciting advancements in healthcare technology and personalized medicine are on the horizon, promising a brighter future for patients worldwide.